4MH-24243-66707
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 554 / MN
- Registered
- 2021-01-30
- Relationship
- Self
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-30
Registered in v-safe
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Impaired work ability, Injection site pain — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: I didn't know there was this v-safe reporting option until after my 2nd shot, which is why I didn't sign up sooner. After my first vaccine, I felt soreness at the injection site and tiredness for about 2 days. After the second injection, I felt all of the symptoms listed above. They were very intense and some of them have lasted for five days now and they have all been quite severe, causing me to miss 2 days of work so far.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): I didn't know there was this v-safe reporting option until after my 2nd shot, which is why I didn't sign up sooner. After my first vaccine, I felt soreness at the injection site and tiredness for about 2 days. After the second injection, I felt all of the symptoms listed above. They were very intense and some of them have lasted for five days now and they have all been quite severe, causing me to miss 2 days of work so far.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Impaired work ability | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release